2013
DOI: 10.1016/s1569-1993(13)60094-6
|View full text |Cite
|
Sign up to set email alerts
|

WS15.6 Development of nanomedicines for the treatment of pulmonary biofilm infections: Insights from advanced fluorescence microscopy studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Negatively charged liposomes consisting of the neutral phospholipid 1,2-dioleoyl- sn -glycero-3-phosphocholine (DOPC) and the anionic phospholipid 1,2-dipalmitoyl- sn -glycero-3-phospho-(1′- rac -glycerol) (DPPG) were prepared by the Thin Film Hydration (TFH) method as described before [19]. After mixing the two lipids in a molar ratio of 8:2 and final lipid concentration of 20 mg mL −1 , a thin lipid film was created by rotary evaporation (Vaccubrand PC 2001, Wertheim, Germany) at 50 °C for 15 min.…”
Section: Methodsmentioning
confidence: 99%
“…Negatively charged liposomes consisting of the neutral phospholipid 1,2-dioleoyl- sn -glycero-3-phosphocholine (DOPC) and the anionic phospholipid 1,2-dipalmitoyl- sn -glycero-3-phospho-(1′- rac -glycerol) (DPPG) were prepared by the Thin Film Hydration (TFH) method as described before [19]. After mixing the two lipids in a molar ratio of 8:2 and final lipid concentration of 20 mg mL −1 , a thin lipid film was created by rotary evaporation (Vaccubrand PC 2001, Wertheim, Germany) at 50 °C for 15 min.…”
Section: Methodsmentioning
confidence: 99%